These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 11518109)
1. Initiation of enzyme replacement therapy for an adult patient with asymptomatic type 1 Gaucher's disease. Tanaka N; Saito H; Ito T; Momose K; Ishida F; Hora K; Kiyosawa K; Ida H Intern Med; 2001 Aug; 40(8):716-21. PubMed ID: 11518109 [TBL] [Abstract][Full Text] [Related]
2. Gaucher's disease in Lithuania: its diagnosis and treatment. Kleinotienė G; Tylki-Szymanska A; Czartoryska B Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991 [TBL] [Abstract][Full Text] [Related]
3. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy. Mazher W; Ali J; Abubakar S; Basar S; Murtaza G J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391 [TBL] [Abstract][Full Text] [Related]
4. Neurological features in Gaucher's disease during enzyme replacement therapy. Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058 [TBL] [Abstract][Full Text] [Related]
5. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement. Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123 [TBL] [Abstract][Full Text] [Related]
6. [Clinical outcomes of 2 pediatric patients with Gaucher's disease in enzyme replacement therapy for 9 years]. Quijada Fraile P; Martín Hernández E; Teresa García-Silva M Med Clin (Barc); 2011 Sep; 137 Suppl 1():43-5. PubMed ID: 22230125 [TBL] [Abstract][Full Text] [Related]
7. [Gaucher's disease and enzyme replacement therapy]. Cornu F Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016 [TBL] [Abstract][Full Text] [Related]
8. [Course of a case of Gaucher's disease type 1 treated over a year with glucocerebrosidase (Cérédase)]. Belmatoug N; Azorin M; Huten D; de Villemeur TB; Carbon C Rev Med Interne; 1993; 14(10):996. PubMed ID: 8009089 [TBL] [Abstract][Full Text] [Related]
10. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI]. Tóth J; Szücs FZ; Benkö K; Maródi L Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625 [TBL] [Abstract][Full Text] [Related]
11. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score. Robertson PL; Maas M; Goldblatt J AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371 [TBL] [Abstract][Full Text] [Related]
12. Alglucerase. A review of its therapeutic use in Gaucher's disease. Whittington R; Goa KL Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease. Altarescu G; Hill S; Wiggs E; Jeffries N; Kreps C; Parker CC; Brady RO; Barton NW; Schiffmann R J Pediatr; 2001 Apr; 138(4):539-47. PubMed ID: 11295718 [TBL] [Abstract][Full Text] [Related]
14. [Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy]. Castelló Girona F; Domínguez Luengo C; del Toro Riera M; Chabás Bergon A An Esp Pediatr; 2001 Mar; 54(3):310-2. PubMed ID: 11262263 [TBL] [Abstract][Full Text] [Related]
16. [Persistence of pulmonary lesions in a 6-year-old boy with type I Gaucher's disease treated by alglucerase since the age of 20 months]. Versteegh C; Avni F; Cuvelier P; Ferster A Arch Pediatr; 1998 Dec; 5(12):1341-3. PubMed ID: 9885741 [TBL] [Abstract][Full Text] [Related]
17. Subtotal splenectomy for Gaucher's disease: a follow-up study. Morgenstern L; Verham R; Weinstein I; Phillips EH Am Surg; 1993 Dec; 59(12):860-5. PubMed ID: 8256944 [TBL] [Abstract][Full Text] [Related]